1-[2-ethyl-3-[[4-(4-fluorophenyl)-1,3-thiazol-2-yl]methyl-methylamino]imidazo[1,2-a]pyridin-6-yl]piperidin-4-ol
C25H28FN5OS — CID 134173508
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[2-ethyl-3-[[4-(4-fluorophenyl)-1,3-thiazol-2-yl]methyl-methylamino]imidazo[1,2-a]pyridin-6-yl]piperidin-4-ol
1-[2-ethyl-3-[[4-(4-fluorophenyl)-1,3-thiazol-2-yl]methyl-methylamino]imidazo[1,2-a]pyridin-6-yl]piperidin-4-ol (PubChem CID 134173508) has the molecular formula C25H28FN5OS and a molecular weight of 465.60 g/mol. Its IUPAC name is 1-[2-ethyl-3-[[4-(4-fluorophenyl)-1,3-thiazol-2-yl]methyl-methylamino]imidazo[1,2-a]pyridin-6-yl]piperidin-4-ol.
Molecular Properties
| Compound Name | 1-[2-ethyl-3-[[4-(4-fluorophenyl)-1,3-thiazol-2-yl]methyl-methylamino]imidazo[1,2-a]pyridin-6-yl]piperidin-4-ol |
|---|---|
| PubChem CID | 134173508 |
| Molecular Formula | C25H28FN5OS |
| Molecular Weight | 465.60 g/mol |
| Exact Mass | 465.20 |
| IUPAC Name | 1-[2-ethyl-3-[[4-(4-fluorophenyl)-1,3-thiazol-2-yl]methyl-methylamino]imidazo[1,2-a]pyridin-6-yl]piperidin-4-ol |
| SMILES | CCc1nc2ccc(N3CCC(O)CC3)cn2c1N(C)Cc1nc(-c2ccc(F)cc2)cs1 |
| InChI | InChI=1S/C25H28FN5OS/c1-3-21-25(29(2)15-24-28-22(16-33-24)17-4-6-18(26)7-5-17)31-14-19(8-9-23(31)27-21)30-12-10-20(32)11-13-30/h4-9,14,16,20,32H,3,10-13,15H2,1-2H3 |
| InChIKey | KLKWSVITEICWHG-UHFFFAOYSA-N |
| XLogP | 4.76 |
| TPSA | 56.90 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 465.60 |
| LogP ≤ 5 | 4.76 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134173508 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.